Texas sues three drug makers alleging Medicaid fraud

Texas on Wednesday filed lawsuits against Mylan Laboratories, Sandoz, Teva Pharmaceuticals and subsidiaries of those companies alleging that the state Medicaid program overpaid retailers by at least tens of millions of dollars for medications because the companies did not disclose discounts they were providing to retailers, the Houston Chronicle reports.

The Texas Medicaid program set reimbursements for drug costs to retailers based on prices reported by drug makers.

State Attorney General Greg Abbott (R) said deep discounts the drug companies provided to retailers were not disclosed to the state.

According to Texas law, retailers are not responsible for the discrepancy because only drug makers are required to report the prices used to calculate reimbursements.

The lawsuit claims the "spread" between what retailers paid for the drugs and the amount they were reimbursed by Medicaid was intended to persuade retailers to buy from the drug companies.

The drug companies did not comment on the lawsuit (Fikac, Houston Chronicle, 6/20).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Obesity crisis in the U.S. expected to worsen by 2050